Start for free
Start for free
Devon Park BioVentures logo

Devon Park BioVentures

North America, Pennsylvania, United States, Wayne

Description

Devon Park Bioventures, located in the Philadelphia metropolitan area, is within driving distance of the headquarters of many of the worlds

Investor Profile

Devon Park BioVentures has made 17 investments, with 0 in the past 12 months and 24% as lead.

Stage Focus

  • Series D (29%)
  • Series C (24%)
  • Series B (18%)
  • Series Unknown (12%)
  • Series A (12%)
  • Debt Financing (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Health Diagnostics
  • Therapeutics
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Devon Park BioVentures frequently co-invest with?

TVM Capital
TVM Capital
Europe, Bayern, Germany, Munich
Co-Investments: 4
MedImmune Ventures
MedImmune Ventures
North America, Maryland, United States, Gaithersburg
Co-Investments: 3
Ascent Biomedical Ventures
Ascent Biomedical Ventures
North America, New York, United States, New York
Co-Investments: 3
Skyline Ventures
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 4
Care Capital
Care Capital
North America, New Jersey, United States, Princeton
Co-Investments: 3
Intersouth Partners
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 5
Alta Partners
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 4
Rho Ventures
Rho Ventures
North America, New York, United States, New York
Co-Investments: 3
Bessemer Venture Partners
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 4
Prism Venture Management
Prism Venture Management
North America, Massachusetts, United States, Needham
Co-Investments: 4

Which angels does Devon Park BioVentures often collaborate with?

I. Wistar Morris III
I. Wistar Morris III
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1

What are some of recent deals done by Devon Park BioVentures?

Cardeas Pharma

Seattle, Washington, United States

Cardeas Pharma specializes in early-phase development of inhaled antibiotics to treat respiratory infections.

BiotechnologyHealth CareMedical
Series BApr 10, 2015
Amount Raised: $37,500,000
Proteon Therapeutics

Waltham, Massachusetts, United States

Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

BiotechnologyMedicalPharmaceutical
Series DMay 16, 2014
Amount Raised: $45,000,000
ZS Pharma

Coppell, Texas, United States

ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series DMar 5, 2014
Amount Raised: $55,000,000
Inotek Pharmaceuticals

Lexington, Massachusetts, United States

Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.

BiotechnologyHealth DiagnosticsPharmaceutical
Debt FinancingSep 27, 2013
Amount Raised: $7,000,000
Inotek Pharmaceuticals

Lexington, Massachusetts, United States

Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.

BiotechnologyHealth DiagnosticsPharmaceutical
Series UnknownSep 27, 2013
Amount Raised: $21,000,000
MicuRx Pharmaceuticals

Foster City, California, United States

MicuRx discovers and develops novel antimicrobials to treat drug-resistant infections and other diseases of significant unmet medical need

BiotechnologyHealth CareMedical
Series BAug 22, 2013
Amount Raised: $25,000,000
ZS Pharma

Coppell, Texas, United States

ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series COct 23, 2012
Amount Raised: $46,000,000
Cardeas Pharma

Seattle, Washington, United States

Cardeas Pharma specializes in early-phase development of inhaled antibiotics to treat respiratory infections.

BiotechnologyHealth CareMedical
Series AJun 7, 2012
Amount Raised: $8,500,000
Cara Therapeutics

Shelton, Connecticut, United States

Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.

BiotechnologyHealth CareTherapeutics
Series DMay 21, 2012
Amount Raised: $4,800,000
Proteon Therapeutics

Waltham, Massachusetts, United States

Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

BiotechnologyMedicalPharmaceutical
Series CAug 12, 2011
Amount Raised: $15,200,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator